Cutting-Edge Robotic Cardiac Surgery within Reach of the Common Man in...
When Mr. Prasad, a 55-year-old heart patient in need of a bypass, first heard of ‘robotic heart surgery', he assumed that it was only for...
Atrial Fibrillation treatment solution by Medtronic
India Medtronic Private Limited, a wholly owned subsidiary of Medtronic plc, a global leader in healthcare technology, announced the launch of Arctic Front™ Cardiac Cryoablation...
PANDEMIC IMPACT ON CARDIVASCULAR DEVICES
COVID-19 has affected global economy in three main ways. Firstly, by directly affecting production and demand, secondly by creating supply chain and market disruption, and thirdly by its financial impact on firms and financial markets. The global cardiovascular market continues to see rapid innovation with new drugs and devices entering the market. - Presented by Gopal Anand
Medcura publishes successful results from the clinical study at Chicago
Medcura, Inc., a commercial-stage medical device company, published the results of a peer-reviewed clinical study at the University of Chicago in this month's Cardiovascular...
Inovise Medical receives device designation to detect the risk of decompensation
Inovise Medical announced the U.S. Food and Drug Administration (FDA) has granted a device designation for its AUDICOR heart failure management system. The system...
RhythMedix launches next-gen RhythmStar Device
RhythMedix, a leader in remote cardiac monitoring released a next-generation RhythmStar wearable device with built-in 4G cellular connectivity. The novel cardiac telemetry monitor is...
Edwards treats the first patient for Mitral Valve Disease
Edwards Lifesciences announced that the first patient has been treated, in the RESTORE clinical trial, which will evaluate the safety and effectiveness of the...
Vital Data Sensor in New Cardiac Monitor receives clearance from FDA
BIOTRONIK announced FDA clearance and availability of the Vital Data Sensor, which identifies body temperature increases potentially associated with fever, in the new BIOMONITOR...
MicroPort CRM launches Clinical Trial for Innovative Axone
MicroPort Cardio Rhythm Management (CRM) announced the first recruitment for the Astral-4LV clinical trial to evaluate the safety and efficacy of Axone, a left...
RenalGuard Therapy prevents AKI after Cardiac Surgery
RenalGuard Therapy protects at-risk patients undergoing cardiac surgery with cardiopulmonary bypass (CPB) from Acute Kidney Injury.
Technological Innovations in Cardiac Surgery
From the successful closure of a patent ductus arteriosus in 1938 and the Blalock- Taussig shunt, discovery and innovation have been the hallmarks of cardiac surgery.
A touch of AI in Cardiology
This article will walk you through the latest advancements in the field of Cardiology - Dr. Magesh Balakrishanan
Predicting leaky heart valves with 3D printing
New integrated workflow improves valve sizing accuracy during aortic valve replacement procedures